| Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis LC Coates, A Kavanaugh, PJ Mease, ER Soriano, ... Arthritis & rheumatology 68 (5), 1060-1071, 2016 | 1096 | 2016 |
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ... Annals of the rheumatic diseases 79 (6), 700-712, 2020 | 993 | 2020 |
| The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity WH Boehncke, S Boehncke, AM Tobin, B Kirby Experimental dermatology 20 (4), 303-307, 2011 | 653 | 2011 |
| S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense Y Huang, K Mao, X Chen, M Sun, T Kawabe, W Li, N Usher, J Zhu, ... Science 359 (6371), 114-119, 2018 | 505 | 2018 |
| Psoriasis: a possible risk factor for development of coronary artery calcification RJ Ludwig, C Herzog, A Rostock, FR Ochsendorf, TM Zollner, D Thaci, ... British Journal of Dermatology 156 (2), 271-276, 2007 | 498 | 2007 |
| The IL-17 family of cytokines in psoriasis: IL-17A and beyond NC Brembilla, L Senra, WH Boehncke Frontiers in immunology 9, 1682, 2018 | 432 | 2018 |
| S3–Guidelines on the treatment of psoriasis vulgaris (English version). Update A Nast, WH Boehncke, U Mrowietz, HM Ockenfels, S Philipp, K Reich, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10, S1-s95, 2012 | 428 | 2012 |
| Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review W Sterry, BE Strober, A Menter, International Psoriasis Council British Journal of Dermatology 157 (4), 649-655, 2007 | 392 | 2007 |
| Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation J Beale, A Jayaraman, DJ Jackson, JDR Macintyre, MR Edwards, ... Science translational medicine 6 (256), 256ra134-256ra134, 2014 | 374 | 2014 |
| Psoriasis patients show signs of insulin resistance S Boehncke, D Thaci, H Beschmann, RJ Ludwig, H Ackermann, ... British Journal of Dermatology 157 (6), 1249-1251, 2007 | 351 | 2007 |
| Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised … A Deodhar, PS Helliwell, WH Boehncke, AP Kollmeier, EC Hsia, ... The Lancet 395 (10230), 1115-1125, 2020 | 344 | 2020 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised … AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ... The Lancet Oncology 22 (5), 643-654, 2021 | 333 | 2021 |
| Proteasome inhibition: a new anti-inflammatory strategy PJ Elliott, TM Zollner, WH Boehncke Journal of molecular medicine 81, 235-245, 2003 | 320 | 2003 |
| Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences WH Boehncke Frontiers in immunology 9, 579, 2018 | 293 | 2018 |
| The role of IL23 and the IL23/TH17 immune axis in the pathogenesis and treatment of psoriasis G Girolomoni, R Strohal, L Puig, H Bachelez, J Barker, WH Boehncke, ... Journal of the European Academy of Dermatology and Venereology 31 (10), 1616 …, 2017 | 274 | 2017 |
| Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis RJ Ludwig, B Boehme, M Podda, R Henschler, E Jager, C Tandi, ... Cancer research 64 (8), 2743-2750, 2004 | 251 | 2004 |
| Etiology and pathogenesis of psoriasis WH Boehncke Rheumatic Disease Clinics 41 (4), 665-675, 2015 | 231 | 2015 |
| Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement P Nash, A Kerschbaumer, T Dörner, M Dougados, RM Fleischmann, ... Annals of the rheumatic diseases 80 (1), 71-87, 2021 | 219 | 2021 |
| Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study A Deodhar, AB Gottlieb, WH Boehncke, B Dong, Y Wang, Y Zhuang, ... The Lancet 391 (10136), 2213-2224, 2018 | 211 | 2018 |
| Clinical picture of heparin-induced thrombocytopenia TE Warkentin Heparin-induced thrombocytopenia, 36-88, 2012 | 205 | 2012 |
